| abstract |
The application specifically provides a fusion protein containing a polypeptide, wherein the polypeptide consists of a fragment of an invariant chain operably linked to an antigen sequence, the invariant chain fragment comprising SEQ ID NO: Consisting of a portion of one residue 17-97, which portion comprises at least five consecutive residues from residues 77-92 of SEQ ID NO: 1. [Selection figure] None |